Concert Pharmaceuticals, Inc. (CNCE)
CNCE Stock Chart More Charts
CNCE Price/Volume Stats
| Current price | $19.60 |
| Prev. close | $19.43 |
| Day low | $19.32 |
| Day high | $19.82 |
| 50-day MA | $19.48 |
| 200-day MA | $20.08 |
| 52-week high | $30.71 |
| 52-week low | $12.67 |
| Volume | 150,258 |
| Avg. volume | 305,607 |
| Dividend yield | N/A |
| Market Cap | 458.64M |
CNCE Returns
| 1-mo | -4.25% |
| 3-mo | -16.95% |
| 6-mo | -23.74% |
| 1-year | 44.01% |
| 3-year | 21.81% |
| 5-year | N/A |
| YTD | -24.24% |
| 2017 | 151.41% |
| 2016 | -45.76% |
| 2015 | 42.42% |
| 2014 | N/A |
| 2013 | N/A |
Concert Pharmaceuticals, Inc. (CNCE) Company Bio
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform (deuterated chemical entity platform) to create novel small molecule drugs. The company was founded in 2006 and is based in Lexington, Massachusetts.
Loading social stream, please wait...